Article thumbnail

P3-200: Daily subcutaneous amifostine facilitates radiation dose escalation for poor risk unresectable stage III lung cancer

By Gregory M. Videtic, Anand Desai, Chandana Reddy, Sujith Kalmadi and Tarek Mekhail
Publisher: 'Ovid Technologies (Wolters Kluwer Health)'
Year: 2008
DOI identifier: 10.1097/01.jto.0000284175.11066.c7
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.